Respiratory Syntactical Virus (RSV) Market Value, Trends, Status, Sales and Growth Rate Market Report Forecast 2020 To 2030

Respiratory Syntactical Virus (RSV) market is estimated to be over US$ 1.73 Billion in 2019. It is anticipated to grow at 10.3% CAGR from 2020 to 2030.

The respiratory syncytial virus is a common and contagious virus, which is capable of affecting the respiratory tract of both adults and children. An RSV infection can also result in serious issues such as bronchiolitis and pneumonia in children younger than 1 year, especially in the United States. As for elderly people, this infection can be the cause of pneumonia, congestive heart failure, can worsen the cases of patients suffering from asthma and chronic obstructive pulmonary disease (COPD).

Major Key Players of the Respiratory Syntactical Virus (RSV) Market are:
Hoffmann-La Roche Ltd., Abbott Laboratories, AbbVie, Inc., AstraZeneca Plc., ReViral Ltd., Becton, Dickinson, and Company (BD), Biocartis Group, BioMérieux SA, Teva Pharmaceuticals Industries, Thermo Fisher Scientific Inc., Danaher Corporation, Gilead Sciences, Inc., GlaxoSmithKline plc., Hologic, Inc., Luminex Corporation, MEDIVIR AB, Merck & Co., Inc., Fast Track Diagnostics Luxembourg S.à r.l., Valeant Pharmaceuticals International, Inc. among others.

Download PDF to Know the Impact of COVID-19 on “Respiratory Syntactical Virus (RSV) Market” at: https://www.marketindustryreports.com/pdf/416

The respiratory syncytial virus market growth is acknowledged owing to the growing global burden of this virus. For instance, the Centers for Disease Control and Prevention’s statistics unveiled that around 177,000 elderly patients are hospitalized due to respiratory syncytial virus among which approximately 14,000 people die in the US per year. Besides, the growth recorded in the neonatal population base along with the robust demand for point of care facilities and in-vitro diagnostics also boost the business revenue generation for the market. Furthermore, the adoption of molecular diagnostics over immunoassays and the high approval rate of RSV diagnostic kits also propels the growth of the RSV market during the projected years.

On the other hand, factors such as the high cost of the treatment along with limited standardization norms for drugs and vaccines coupled with the existence of other pathogens resulting in similar respiratory distress conditions are likely to hamper the business growth. Alongside this, the innovations in diagnostic methods are expected to offer lucrative market growth opportunities in the near future. However, the on-going developments of RSV vaccines pose a major threat, hampering the global market growth.

The Respiratory Syntactical Virus (RSV) Market is segmented on the basis of Drugs Type , Diagnostics Method, End-User and region

Major Drugs Type of Respiratory Syntactical Virus (RSV) Market covered are:

• Ribavirin
• Palivizumab

Major Diagnostics Method of Respiratory Syntactical Virus (RSV) Market covered are:

• Direct Fluorescent Antibody Method
• Rapid Antigen Diagnostic Test
• Molecular Diagnostics
• Gel Microdroplets
• Chromatographic Immunoassay
• Diagnostic Imaging
• Flow Cytometry

Major End-User of Respiratory Syntactical Virus (RSV) Market covered are:

• Drug Stores and Retail Pharmacies
• Clinical Laboratories
• Hospitals and Clinics

Moreover, there is no approved drug or vaccine available to prevent or treat this infection. However, the patients are treated only by administrating prophylaxis drugs, including Palivizumab. However, the key player is focusing on the invention and development of a drug or a vaccine with better efficiency. This, in turn, favors the expansion of the global respiratory syncytial virus industry size. For instance, the efforts of Astra Zeneca resulted in the market approval of Synagis, the only approved immune-prophylaxis for pediatrics. In addition, Novavax Inc.’s achievement to compete in Phase 3 trials for RSV F Nanoparticle for maternal applications is also favoring the market growth.

Research objectives:-

– To study and analyze the global Respiratory Syntactical Virus (RSV) consumption (value & volume) by key regions/countries, product type and application, history data.

– To understand the structure of the Respiratory Syntactical Virus (RSV) market by identifying its various sub-segments.

– Focuses on the key global Respiratory Syntactical Virus (RSV) manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.

– To analyze the Respiratory Syntactical Virus (RSV) with respect to individual growth trends, future prospects, and their contribution to the total market.

– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Have any query? Inquiry about report at: https://www.marketindustryreports.com/inquiry/416

Table of Contents

1. INTRODUCTION
   1. Market Definition
   2. Market Classification
   3. Geographic Scope
   4. Years Considered for the Study
   5. Currency Used
2. RESEARCH METHODOLOGY
   1. Research Framework
   2. Data Collection Technique
   3. Data Sources
   4. Market Estimation Methodology
   5. Data Validation and Triangulation
3. ABSTRACT OF THE STUDY
4. MARKET DYNAMICS ASSESMENT
   1. Overview
   2. Drivers
   3. Barriers/Challenges
   4. Opportunities
5. UNIQUE SELLING PROPOSITION (USP)
   1. COVID-19 Impact Assessment on Respiratory Syntactical Virus (RSV) Market
6. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET – ANALYSIS & FORECAST, BY DRUGS TYPE
   1. Palivizumab
   2. Ibavirin
   3. Others
7. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET – ANALYSIS & FORECAST, BY DOSAGE FORM
   1. Oral
   2. Injectable
   3. Others
8. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV)MARKET – ANALYSIS & FORECAST, BY DIAGNOSTICS METHODS
   1. Direct Fluorescent Antibody (DFA) Method
   2. Rapid Antigen Diagnostic Test (RADTs)
   3. Molecular Diagnostics
   4. Chromatographic Immunoassay
   5. Gravity Driven Test
   6. Oligochromatography (OC)
   7. Diagnostic Imaging
   8. Gel Microdroplets
   9. Flow Cytometry
   10. Others
9. GLOBAL RESPIRATORY SYNTACTICAL VIRUS (RSV) MARKET – ANALYSIS & FORECAST, BY END USE
   1. Hospitals and Clinics
   2. Drug Stores and Retail Pharmacies
   3. Clinical Laboratories
   4. Others
10. GLOBAL Respiratory Syntactical Virus (RSV)MARKET – ANALYSIS & FORECAST, BY REGION
    1. North America Respiratory Syntactical Virus (RSV) Market
    2. Europe Respiratory Syntactical Virus (RSV) Market
    3. Asia Pacific Respiratory Syntactical Virus (RSV) Market
    4. Rest of the World (ROW) Respiratory Syntactical Virus (RSV) Market
11. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)*
    1. Abbott Laboratories
    2. AbbVie, Inc.
    3. AstraZeneca plc.
    4. Becton, Dickinson and Company (BD)
    5. Biocartis Group
    6. BioMérieux SA
    7. Danaher Corporation
    8. Hoffmann-La Roche Ltd.
    9. Fast Track Diagnostics Luxembourg S.à r.l.
    10. Gilead Sciences, Inc.
    11. GlaxoSmithKline plc.
    12. Hologic, Inc.
    13. Luminex Corporation
    14. MEDIVIR AB
    15. Merck & Co., Inc.
    16. ReViral Ltd.
    17. Teva Pharmaceuticals Industries Ltd.
    18. Thermo Fisher Scientific Inc.
    19. Valeant Pharmaceuticals International, Inc.

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain

Buy Exclusive Report @ https://www.marketindustryreports.com/checkout/416

In the end, DNA Test Kits industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

About Market Industry Reports-

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us-
Email: sales@marketindustryreports.com
Phone: + 91 8956767535
Website: https://www.marketindustryreports.com